Clinical Trial Update: The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating initial triple oral therapy versus initial dual therapy in newly diagnosed pulmonary arterial hypertension; results and safety data hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2020-09-11